Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
1996 3
1997 5
1998 3
1999 3
2000 2
2001 2
2002 1
2003 1
2004 2
2005 3
2006 1
2007 4
2008 8
2009 1
2010 4
2011 1
2012 2
2013 5
2014 5
2015 2
2016 2
2017 5
2018 3
2019 5
2020 5
2021 5
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

83 results

Results by year

Filters applied: . Clear all
Page 1
Comparison of operative and postoperative characteristics and outcomes between thoracoscopic segmentectomy and lobectomy for non-small-cell lung cancer: a propensity score matching study from the Italian VATS Group Registry.
Dell'Amore A, Lomangino I, Cannone G, Terzi S, Pangoni A, Lorenzoni G, Nicotra S, Schiavon M, Zuin A, Gregori D, Crisci R, Curcio C, Rea F; Italian VATS Group. Dell'Amore A, et al. Eur J Cardiothorac Surg. 2022 Feb 18;61(3):533-542. doi: 10.1093/ejcts/ezab430. Eur J Cardiothorac Surg. 2022. PMID: 34643695
OBJECTIVES: Only few studies compared the surgical morbidity and mortality of thoracoscopic segmentectomy versus lobectomy for non-small-cell lung cancer, in particular, by relating the segmental resections with the corresponding anatomical lobes. ...
OBJECTIVES: Only few studies compared the surgical morbidity and mortality of thoracoscopic segmentectomy versus lobectomy for non-small-cel …
Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer.
Mozzoni P, Banda I, Goldoni M, Corradi M, Tiseo M, Acampa O, Balestra V, Ampollini L, Casalini A, Carbognani P, Mutti A. Mozzoni P, et al. Among authors: carbognani p. Biomarkers. 2013 Dec;18(8):679-86. doi: 10.3109/1354750X.2013.845610. Epub 2013 Oct 8. Biomarkers. 2013. PMID: 24102090
Lung cancer is a major cause of death in Western countries. Current screening methods are invasive and still lead to a high percentage of false positives. There is, therefore, a need to find biomarkers that increase the probability of detecting lung cancer …
Lung cancer is a major cause of death in Western countries. Current screening methods are invasive and still lead to a high pe …
Metallic elements in pulmonary biopsies from lung cancer and control subjects.
De Palma G, Goldoni M, Catalani S, Carbognani P, Poli D, Mozzoni P, Acampa O, Internullo E, Rusca M, Apostoli P. De Palma G, et al. Among authors: carbognani p. Acta Biomed. 2008;79 Suppl 1:43-51. Acta Biomed. 2008. PMID: 18924309
Occupational/environmental exposure to some metallic elements is a risk factor for the development of lung diseases, including lung cancer. We aimed at investigating the levels of arsenic, beryllium, cadmium, cobalt, chromium, nickel and lead in the lung …
Occupational/environmental exposure to some metallic elements is a risk factor for the development of lung diseases, including lun …
YKL-40 and mesothelin in the blood of patients with malignant mesothelioma, lung cancer and asbestosis.
Corradi M, Goldoni M, Alinovi R, Tiseo M, Ampollini L, Bonini S, Carbognani P, Casalini A, Mutti A. Corradi M, et al. Among authors: carbognani p. Anticancer Res. 2013 Dec;33(12):5517-24. Anticancer Res. 2013. PMID: 24324091
PATIENTS AND METHODS: The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b) patients with MM; (c) patients with non-small cell lung cancer; and (d) controls without any evidence of malignancy. ...
PATIENTS AND METHODS: The study involved four groups: (a) individuals previously exposed to asbestos with asbestosis; (b) patients with MM; …
Post-operative outcomes and quality of life assessment after thoracoscopic lobectomy for Non-small-cell lung cancer in octogenarians: Analysis from a national database.
Bongiolatti S, Gonfiotti A, Borgianni S, Crisci R, Curcio C, Voltolini L; Italian VATS Group. Bongiolatti S, et al. Surg Oncol. 2021 Jun;37:101530. doi: 10.1016/j.suronc.2021.101530. Epub 2021 Feb 1. Surg Oncol. 2021. PMID: 33548589
BACKGROUND: Thoracoscopic lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) is a well-established option for early stage NSCLC, but the evidences are limited for octogenarians. ...
BACKGROUND: Thoracoscopic lobectomy (VATS-L) for non-small-cell lung cancer (NSCLC) is a well-established option for early sta …
Blood and lymphatic vessels contribute to the impact of the immune microenvironment on clinical outcome in non-small-cell lung cancer.
Armani G, Madeddu D, Mazzaschi G, Bocchialini G, Sogni F, Frati C, Lorusso B, Falco A, Lagrasta CA, Cavalli S, Mangiaracina C, Vilella R, Becchi G, Gnetti L, Corradini E, Quaini E, Urbanek K, Goldoni M, Carbognani P, Ampollini L, Quaini F. Armani G, et al. Among authors: carbognani p. Eur J Cardiothorac Surg. 2018 Jun 1;53(6):1205-1213. doi: 10.1093/ejcts/ezx492. Eur J Cardiothorac Surg. 2018. PMID: 29346540
The aim of this study was to determine whether the interplay between the lymphatic and the blood microvasculature, tumour-infiltrating lymphocytes and the programmed death 1 (PD-1)/programmed death ligand 1 (PD-L1) immune checkpoint constitutes an immune microenvironment affectin …
The aim of this study was to determine whether the interplay between the lymphatic and the blood microvasculature, tumour-infiltrating lymph …
Multiple primary malignancies involving lung cancer: a single-center experience.
Ventura L, Carbognani P, Gnetti L, Rossi M, Tiseo M, Silini EM, Sverzellati N, Silva M, Succi M, Braggio C, Cattadori S, Bocchialini G, Balestra V, Rusca M, Ampollini L. Ventura L, et al. Among authors: carbognani p. Tumori. 2021 Jun;107(3):196-203. doi: 10.1177/0300891620933678. Epub 2020 Jun 24. Tumori. 2021. PMID: 32578517
Among the 222 patients with MPM enrolled, 204 (91.8%) had two malignancies, while 18 (8.2%) had three malignancies, 38 (17.1%) were synchronous, 41 (18.5%) had lung cancer first (LCF) and 181 (81.5%) had other cancer first (OCF). ...CONCLUSIONS: Prostate, col …
Among the 222 patients with MPM enrolled, 204 (91.8%) had two malignancies, while 18 (8.2%) had three malignancies, 38 (17.1%) were synchron …
Prognostic factors of lung cancer in lymphoma survivors (the LuCiLyS study).
Fiorelli A, D'Andrilli A, Carlucci A, Vicidomini G, Loizzi D, Ardò NP, Marasco RD, Ventura L, Ampollini L, Carbognani P, Bocchialini G, Lococo F, Paci M, Di Stefano TS, Ardissone F, Gagliasso M, Mendogni P, Rosso L, Mazzucco A, Vanni C, Marinucci BT, Potenza R, Matricardi A, Ragusa M, Tassi V, Anile M, Poggi C, Serra N, Sica A, Nosotti M, Sollitto F, Venuta F, Rendina EA, Puma F, Santini M; LuCiLyS study group. Fiorelli A, et al. Among authors: carbognani p. Transl Lung Cancer Res. 2020 Feb;9(1):90-102. doi: 10.21037/tlcr.2019.12.28. Transl Lung Cancer Res. 2020. PMID: 32206557 Free PMC article.
Limited information exists about the treatment and prognosis of second lung cancer following lymphoma. Herein, we evaluated the outcome and prognostic factors of Lung Cancer in Lymphoma Survivors (the LuCiLyS study) to improve the patient selection for …
Limited information exists about the treatment and prognosis of second lung cancer following lymphoma. Herein, we evaluated th …
Pulmonary Hamartoma Associated With Lung Cancer (PHALC Study): Results of a Multicenter Study.
Fiorelli A, D'Andrilli A, Carlucci A, Vicidomini G, Argento G, Trabalza Marinucci B, Ardissone F, Rapanà R, Sobrero S, Carbognani P, Ventura L, Bocchialini G, Ragusa M, Tassi V, Sollitto F, Loizzi D, Ardò NP, Anile M, Puma F, Rendina EA, Venuta F, Serra N, Santini M. Fiorelli A, et al. Among authors: carbognani p. Lung. 2021 Aug;199(4):369-378. doi: 10.1007/s00408-021-00460-8. Epub 2021 Jul 24. Lung. 2021. PMID: 34302497 Free PMC article.
PURPOSE: Pulmonary hamartoma is the most common benign tumor of the lung. We analyzed a 20-year historical series of patients with pulmonary hamartoma undergoing surgical resection, aiming to evaluate the characteristics, the outcomes, and the association between hamartoma …
PURPOSE: Pulmonary hamartoma is the most common benign tumor of the lung. We analyzed a 20-year historical series of patients with pu …
Relationship Between the Diffusing Capacity of the Lung for Carbon Monoxide (DLCO) and Lung Adenocarcinoma Patterns: New Possible Insights.
Ventura L, Gnetti L, Milanese G, Rossi M, Leo L, Cattadori S, Silva M, Leonetti A, Minari R, Musini L, Nicole P, Magrini FI, Bocchialini G, Silini EM, Tiseo M, Sverzellati N, Carbognani P. Ventura L, et al. Among authors: carbognani p. Arch Bronconeumol. 2023 Jul;59(7):418-426. doi: 10.1016/j.arbres.2023.03.015. Epub 2023 Mar 23. Arch Bronconeumol. 2023. PMID: 37032196 English, Spanish.
INTRODUCTION: This study aimed to evaluate a potential relationship between the diffusing capacity of the lung for carbon monoxide (DLCO) and the aggressiveness of lung adenocarcinoma (ADC). METHODS: Patients who underwent radical surgery for lung ADC between …
INTRODUCTION: This study aimed to evaluate a potential relationship between the diffusing capacity of the lung for carbon monoxide (D …
83 results